STACY MARSH: Open Payments
NPI 1659433092 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,911 in 94 payments from 18 companies in 2025. Trend: 2023 $1,984 · 2024 $1,916 · 2025 $1,911
Food & beverage: $1,899Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $240 |
| Vanda Pharmaceuticals Inc. | 9 | $232 |
| GlaxoSmithKline, LLC. | 13 | $228 |
| Phathom Pharmaceuticals, Inc. | 14 | $199 |
| AstraZeneca Pharmaceuticals LP | 7 | $163 |
| Exact Sciences Corporation | 6 | $158 |
| Astellas Pharma US Inc | 6 | $141 |
| Novo Nordisk Inc | 6 | $118 |
| Sumitomo Pharma America, Inc. | 4 | $103 |
| Lilly USA, LLC | 3 | $92 |
Products named: FANAPT, VOQUEZNA, TRELEGY ELLIPTA, Veozah, VRAYLAR, GEMTESA, Cologuard Collection Kit, MOUNJARO.
Industry payments across CT — which companies pay providers there.
